5-Iodo-cytidine

Catalog No.: 
ACZGVO763
CAS No.: 
1147-23-5
Molecular Formula: 
C9H12IN3O5
Molecular Weight: 
369.11
5-Iodo-cytidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10g98%$82.00In stockInquiry
25g98%$197.00In stockInquiry
100g98%$603.00In stockInquiry
500g98%$2412.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Iodo-cytidine
IUPAC Name4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidin-2(1H)-one
MDL No.MFCD00056070
Molecular FormulaC9H12IN3O5
Molecular Weight369.11
SMILESNC1=NC(=O)N(C=C1I)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
InChI KeyLQQGJDJXUSAEMZ-UAKXSSHOSA-N
Synonym4-Amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidin-2(1H)-one | C9H12IN3O5 | 4-Imino-5-iodo-1-pentofuranosyl-1,4-dihydropyrimidin-2-ol | LQQGJDJXUSAEMZ-UAKXSSHOSA-N | DS-14589 | AMY22101 | SCHEMBL770112 | Cytidine
CAS No.1147-23-5
PubChem CID159359

Synthetic Route by SureRoute

1. ACZGVO763 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZGVO763 route product structure diagram
    ACZGVO7631147-23-5In Stock
Inquiry

2. ACZGVO763 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRGAB582 route compound structure diagram
    ACRGAB5821122-44-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZGVO763 route product structure diagram
    ACZGVO7631147-23-5In Stock
Inquiry

3. ACZGVO763 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZGVO763 route product structure diagram
    ACZGVO7631147-23-5In Stock
Inquiry

Comments (0)